Alston & Bird LLP is a prominent firm for matters at the intersection of antitrust and intellectual property law, particularly in the technology and pharmaceutical sectors. The team’s niche expertise in pharmaceuticals includes the Hatch-Waxman regulatory framework and reverse payment disputes. In Atlanta, Georgia, co-chair Matthew Kent has extensive experience defending pharmaceutical companies in private antitrust litigation. Fellow co-chair Valarie Williams, based in San Francisco, excels in resolving high-profile antitrust issues both in and out of the courtroom. Also on the West Coast, Teresa Bonder has significant experience representing clients in antitrust claims within the pharmaceutical and financial services industries, brought by consumer classes, competitors, and trade associations.
Legal 500 Editorial commentary
- Profile
Key clients
- Microsoft
- U.S. Bancorp
- Fieldale Farms
- AliveCor
- Truist
- Glenmark
- Auto Auction Services Corporation
- McLane Company
- LexisNexis
- Sandoz
Work highlights
- Representing Microsoft as trial counsel in a lawsuit filed by civil plaintiffs aiming to block the company’s acquisition of Activision Blizzard.
- Represented Sandoz at trial against United Therapeutics in a case pending since 2019.
- Counsel for Glenmark in multiple reverse payment putative class actions alleging antitrust conspiracy.
Lawyers
Practice head
Matthew Kent; Valarie Williams; John Snyder
Other key lawyers
Teresa Bonder; Alex Brown; Parker Miller; Andrew Hatchett